ALPHAMAB-B (09966) announced that its board of directors resolved on November 7, 2025, to repurchase the company's ordinary shares from the open market from time to time, with a maximum repurchase amount of HKD 30 million.

The board believes the current trading price of the shares does not accurately reflect the company's intrinsic value. It also views the share repurchase as a demonstration of confidence in the company's business outlook and prospects, which will ultimately benefit the company and create value for shareholders.

The board is confident that the company's current financial resources are sufficient to support the proposed share repurchase while maintaining a sound financial position.